Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Español Near me My list Help
US Patient GuideUSA
Surprise me
Prescription medicine · generic available

Desmopressin acetate

Brand names: Ddavp, Stimate, Desmoda

Full FDA label All drugs

Official FDA data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the drug label, the NDC Directory, Drugs@FDA, recall reports and the drug shortage list. Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

At a glance

YesBoxed warning
None listedFDA shortage list
1Recalls (FDA reports)
27Companies
1984First FDA approval on file

Quick answers

What is Desmopressin acetate used for?
The FDA-approved label (Ddavp, Ferring Pharmaceuticals Inc., September 28, 2022) says: “DDAVP Injection is a vasopressin analog used for: Central Diabetes Insipidus - as antidiuretic replacement therapy in the management of central (cranial) diabetes insipidus and for the management of the temporary polyuria and polydipsia following head trauma or surgery in the pituitary region. …” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Does Desmopressin acetate have a boxed warning?
Yes. The FDA label for Ddavp has a boxed warning, the FDA’s strongest warning. Read it on the full label and ask your pharmacist.
Is there a shortage of Desmopressin acetate?
No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
Has Desmopressin acetate been recalled?
FDA enforcement reports list 1 recall of products of this medicine; the newest started November 23, 2022 (Class II). A recall usually concerns specific lots, not every product.
Who makes Desmopressin acetate?
27 companies list prescription products of Desmopressin acetate in the FDA NDC Directory, including Nordic Pharma, Inc., Ferring Pharmaceuticals Inc. and Sun Pharmaceutical Industries, Inc..

What Desmopressin acetate is used for

Quoted from the “Indications and Usage” section of the FDA-approved label.

DDAVP Injection is a vasopressin analog used for: Central Diabetes Insipidus - as antidiuretic replacement therapy in the management of central (cranial) diabetes insipidus and for the management of the temporary polyuria and polydipsia following head trauma or surgery in the pituitary region. …

— FDA label: Ddavp, Ferring Pharmaceuticals Inc., effective September 28, 2022. Read the full label on DailyMed →

The FDA has 37 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.

Boxed warning

A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.

This label has a boxed warning. Read it on the full label →

20 of 37 FDA labels for this medicine have a boxed warning.

Forms and how it is given

Dosage formsTablet · Injection, solution · Injection · Solution · Spray
RouteIntravenous · Subcutaneous · Oral · Nasal
Prescription products51 in the FDA NDC Directory
Brand namesDdavp, Stimate, Desmoda

What pharmacies pay (NADAC)

The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.

This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.

NADAC per unit for Desmopressin acetate, by strength and form
Strength and formGeneric or brandPharmacies pay
desmopressin acetate 0.1 mg
tablet		 Generic $0.2352 per tablet
desmopressin acetate 0.2 mg
tablet		 Generic $0.3800 per tablet
desmopressin acetate 4 ug/mL
injection, solution		 Generic $18.44 per mL
desmopressin acetate 4 ug/mL
solution		 Generic $18.44 per mL
desmopressin acetate 40 ug/10 mL
injection, solution		 Generic $18.44 per mL

NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.

Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →

Companies that list this medicine

Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.

FDA approval history

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
  • ANDA: Abbreviated New Drug Application: how a generic version is approved.
Brand and biologic applications
ApplicationSponsorApprovedLater changes approved
NDA018938
DDAVP		 J MolnerMarch 30, 1984 14, latest July 21, 2022
2022: Labeling · 2018: Labeling · 2015: Labeling
NDA019955
DDAVP		 Ferring Pharms IncSeptember 6, 1995 7, latest February 28, 2014
2014: Manufacturing (CMC) · 2007: Labeling · 2005: Labeling
NDA020355
STIMATE, STIMATE (NEEDS NO REFRIGERATION)		 Ferring Pharms IncMarch 7, 1994 11, latest July 15, 2026
2026: Labeling · 2013: Manufacturing (CMC) · 2013: Labeling
NDA219873
DESMODA		 EtonFebruary 25, 2026 —

Generic approvals (15)

Shortage status

The FDA drug shortage list does not show these products.

FDA Drug Shortages database →

Recalls

From FDA enforcement reports, matched by the product’s NDC code. A recall usually covers specific lots only: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.

  1. November 23, 2022 · Class II · Terminated · D-0072-2023

    Subpotent Drug

    Desmopressin Acetate Tablets 0.2mg, 100-count bottles, RX Only, Distributed by: Avet Pharmaceuticals Inc. East Brunswick, NJ 08816, NDC 23155-490-01 — Heritage Pharmaceuticals Inc

What do the recall classes mean?

Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).

Official identifiers

RxCUI (RxNorm)833008, 849501, 849503, 849506, 849515, 849517, 849524, 1723232, 1723234, 1797859 … (+3)
SPL set ID of the quoted label651f6fee-a2c7-431b-8d5d-58b156c72244
FDA labels (SPL)37
FDA applicationsNDA018938, NDA019955, NDA020355, NDA219873, 15 ANDA
Active ingredients (FDA)DESMOPRESSIN ACETATE

Sources

  1. FDA-approved label on DailyMed (National Library of Medicine) — Ddavp, Ferring Pharmaceuticals Inc., effective September 28, 2022; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
  2. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026

openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →

Report an error → · Information for medicine makers